Table 2 Implications of different purification/selection techniques
Protocol | Viability (% mean) | % Mean±s.d.a | |||||
|---|---|---|---|---|---|---|---|
CD19 + | CD14 + | CD3 + | CD4 + | CD8 + | CD161 + | ||
(1) Filtration | 88.1 | 7.3±0.3 | 15.2±0.5 | 36.8±1.8 | 7.2±4.7 | 19.2±4.6 | 18.7±5.3 |
(2) Filtration and fluorescence gatingb | 88.1 | 6.6±0.2 | 5.8±0.6 | 50.0±2.5 | 13.4±7.3 | 25.1±3.8 | 25.2±2.7 |
(3) CD2 beads and fluorescence gating | 95.4 | 0.8±0.4 | 4.2±0.5 | 77.5±4.8 | 18.8±5.6 | 36.4±8.7 | 18±3.3 |
(4) CD56 beads and fluorescence gating | 97.3 | 0.3±0.081 | 0.5±0.1 | — | — | — | 52.6±2.8 |